GlassScriptPhysician profile
Ramakrishnan Unni
NPI 1063493542
$1,512.79
in general payments reported to CMS, 2019-2025
23 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $45.31 · 2021: $116 · 2022: $168 · 2023: $136 · 2024: $267 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $193.72 | 2019-2025 | Erleada |
| Ekos Corporation | $168.33 | 2019 | |
| Lilly USA, LLC | $125.00 | 2024 | Jardiance |
| Novo Nordisk INC | $125.00 | 2022 | |
| Photocure INC | $121.13 | 2019-2024 | Cysview |
| Boston Scientific Corporation | $113.33 | 2019 | |
| Travere Therapeutics, INC. | $101.76 | 2019 | |
| Merck Sharp & Dohme LLC | $95.67 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $71.75 | 2019-2025 | |
| Axonics, INC. | $62.79 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $42.70 | 2021 | |
| Olympus America INC. | $41.16 | 2025 | Itind System |
| Astellas Pharma US INC | $40.88 | 2019 | |
| Laborie Medical Technologies Corp. | $38.74 | 2023 | |
| Neotract INC. | $32.85 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.06 | 2020 | |
| Tolmar, INC. | $20.40 | 2023 | |
| Cardinal Health 414 LLC | $18.93 | 2023 | |
| Foundation Medicine, INC. | $18.25 | 2020 | |
| Coopersurgical, INC. | $14.49 | 2019 | |
| Pfizer INC. | $13.70 | 2022 | |
| Mission Pharmacal Company | $12.61 | 2019 | |
| Metuchen Pharmaceuticals | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramakrishnan Unni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.